Given the primary role of chemotherapy resistance in SCLC treatment failure, we developed a cell-based and patient-derived chemoresistant SCLC xenograft models and used them to evaluate the efficacy of combination treatment with an ERRγ antagonist and chemotherapy for inhibiting tumor growth and metastasis. The gene discussed is ESRRG; the disease is small cell lung carcinoma.